• LAST PRICE
    1.1200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.1000/ 5
  • Ask / Lots
    1.1700/ 18
  • Open / Previous Close
    0.0000 / 1.1200
  • Day Range
    ---
  • 52 Week Range
    Low 0.8150
    High 6.2500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 1.16
TimeVolumeBJDX
09:32 ET131911.1585
09:34 ET20001.1533
09:41 ET4001.1585
09:52 ET3001.16
09:57 ET20001.1501
10:06 ET6001.15
10:08 ET15141.15
10:14 ET75161.15
10:19 ET11501.14
10:21 ET20001.1309
10:26 ET15001.1301
10:28 ET3081.14
10:32 ET12001.148
10:33 ET5001.1307
10:37 ET7001.135
10:39 ET34301.13
11:06 ET44601.1301
11:15 ET3001.13
11:20 ET13791.13
11:36 ET1001.1294
11:42 ET2301.1292
11:49 ET1001.13
11:51 ET1501.125
11:58 ET17001.1296
12:00 ET3001.1299
12:02 ET1511.1246
12:34 ET2001.1256
12:38 ET86271.1201
01:35 ET1001.11
01:53 ET2441.1199
02:08 ET50001.129
02:15 ET4771.1299
02:24 ET2881.12
02:29 ET5001.1288
02:44 ET14001.1128
02:47 ET10001.1188
03:21 ET3001.1293
03:38 ET42371.1272
03:39 ET1501.1289
03:45 ET1001.125
03:56 ET21021.12
03:57 ET1001.125
03:59 ET8071.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBJDX
Bluejay Diagnostics Inc
22.6M
-2.8x
---
United StatesPETV
PetVivo Holdings Inc
21.5M
-3.9x
---
United StatesRNXT
RenovoRx Inc
23.8M
-2.6x
---
United StatesRMSL
REMSleep Holdings Inc
25.8M
-2.9x
---
United StatesWHSI
Wearable Health Solutions Inc
25.2M
0.0x
---
United StatesFEMY
Femasys Inc
24.7M
-2.9x
---
As of 2022-08-10

Company Information

Bluejay Diagnostics, Inc. is engaged in the developing medical diagnostics tests devices. The Company offers diagnostic testing in infectious, inflammatory and metabolic diseases by using its Symphony platform. Symphony platform is an automated diagnostic system, consisting of a fluorescence immuno-analyzer which uses a single-use diagnostic test cartridge with reagents integrated in the cartridge. The Company is developing a pipeline of diagnostic tests for Symphony, including triage of myocardial infarction (MI), congestive heart failure (CHF), neutropenic sepsis in cancer, and other disease diagnostic indications using the same Symphony platform. The Company's Symphony IL-6 product candidate is for early and rapid identification of sepsis during Emergency Department (ED), critical care triage, and neutropenic sepsis in oncology patients. Symphony IL-6 product candidate is also for monitoring disease progression during such treatment regimen.

Contact Information

Headquarters
360 Massachusetts Avenue, Suite 203ACTON, MA, United States 01720
Phone
978-631-0152
Fax
302-636-5454

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$22.6M
Revenue (TTM)
$249.0K
Shares Outstanding
20.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.41
Book Value
$1.01
P/E Ratio
-2.8x
Price/Sales (TTM)
90.6
Price/Cash Flow (TTM)
---
Operating Margin
-2,561.79%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.